Delivery Order SPE2DB22D1103-SPE2DB24FTDR4
Award Date 1/10/24
Potential Completion Date 1/11/24
Potential Value $1.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide TWINRIX VACCINE SYRINGEML. The $11,112.95 contract has a performance period through January 29, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp has received numerous prior awards from DLA Troop Support Medical to supply pharmaceuticals, medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $7,197.42 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the supply of TWINRIX VACCINE SYRINGE ML. The contract has an ultimate completion date of March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE ML pharmaceutical product. The $1,352.76 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and has received numerous prior contracts from DLA to supply pharmaceuticals and medical supplies in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX vaccine in pre-filled syringes. The $66,709.68 contract has a completion date of January 3, 2024. Amerisourcebergen, as the prime contractor, will deliver the pharmaceutical products from its corporate office location in Conshohocken, Pennsylvania. This award is part of Amerisourcebergen's broader work...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $13,392.80 firm fixed price delivery order is for the supply of TWINRIX Vaccine Syringes to support military treatment programs and facilities. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is part of a larger indefinite delivery contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for the supply of TWINRIX VACCINE SYRINGEML, a pharmaceutical product, with a ceiling value of $1,940.88 and an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,595.00 firm fixed-price delivery order is for the procurement of TWINRIX VACCINE SYRINGEML, with a period of performance through April 10, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $7,408.40 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,028.32 firm fixed-price delivery order is for the supply of 4,564,828,550 units of the TWINRIX vaccine syringe. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of TWINRIX VACCINE SYRINGEML. The award has a ceiling value of $14,927.78 and an ultimate completion date of August 20, 2024. The contract is a Firm Fixed Price type. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTDR4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TWINRIX VACCINE SYRINGEML. The $1,813.34 firm fixed price delivery order has a completion date of January 11, 2024. As a prime contractor, Amerisourcebergen Drug Corp has a history of supplying pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical programs and facilities. The contract has no set-aside designation. Amerisourcebergen Drug Corp's parent company, Cencora, Inc., also does business as Amerisourcebergen.
Generated 4/10/24, 9:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/10/24 |